And with the hospital and university doing all the clinical research the pharma. company saves time and money if the findings come to any fruition.
If successful they can use on the findings of the hospital and university to cash in due to their joint venture agreement with them. So basically the taxpayers of Britain are financing the research through the university and hospital. ValiRx is avoiding the upfront expenses since the university and hospital are doing it. ValiRx takes a short cut to the marketplace if the therapy becomes a true avenue to attack cancer. If it becomes marketable they will gouge US patients since Europe and Canada are government controlled healthcare. As we have seen here in the US, pharma. companies are doing the same thing here using US universities to do the research and trials. Some even contract with doctors to do the clinical research since the doctors have a group of patients to chose from for clinical research.
Oncology is expensive and a big money maker in the US healthcare arena.
Many thankQs for the info!
Very expensive in 2019 each dose of Rituxan used to treat certain NHL was $39,000. here in NC. Multiple doses are required including “maintenance” doses. Each dose requires drugs to prevent adverse reactions and it is sometimes given in combination with other chemotherapy drugs. The drugs used to help restore platelets or white blood cell are astronomical in cost as well. Oncology is really big money maker.